British Society of Gastroenterology position statement on serrated polyps in the colon and rectum

Gut

Volumn 66, Issue 7, 2017, Pages 1181-1196

  East, James E ^a   Atkin, Wendy S ^b   Bateman, Adrian C ^c   Clark, Susan K ^d   Dolwani, Sunil ^e   Ket, Shara N ^a   Leedham, Simon J ^f   Phull, Perminder S ^g   Rutter, Matt D ^h,i   Shepherd, Neil A ^j   Tomlinson, Ian ^f   Rees, Colin J ^i,k  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d ST MARK S HOSPITAL   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^h UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

ⁱ DURHAM UNIVERSITY   (United Kingdom)

^j CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^k CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

COLONIC NEOPLASMS; COLONOSCOPY; COLORECTAL CANCER; HISTOPATHOLOGY; POLYPOSIS

Indexed keywords

SCOPOLAMINE BUTYL BROMIDE; BIOLOGICAL MARKER; CHOLINERGIC RECEPTOR BLOCKING AGENT; DNA;

BENCHMARKING; CANCER RISK; CHROMOENDOSCOPY; CLINICAL AUDIT; CLINICAL FEATURE; COLITIS; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; CPG ISLAND; GASTROINTESTINAL POLYPOSIS; GASTROINTESTINAL SURGERY; HEALTH EDUCATION; HUMAN; INTESTINE PREPARATION; MEDICAL SOCIETY; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; RECTUM POLYP; REVIEW; SERRATED COLON POLYP; SERRATED POLYPOSIS SYNDROME; SERRATED RECTUM POLYP; ADENOMA; ADENOMATOUS POLYPOSIS COLI; CELL TRANSFORMATION; CHEMISTRY; COLONIC POLYPS; COMPLICATION; DNA METHYLATION; FECES; GENETICS; ISOLATION AND PURIFICATION; NOMENCLATURE; POLYPS; PRACTICE GUIDELINE; PRECANCEROUS CONDITIONS; RECTAL DISEASES; WATCHFUL WAITING;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; BENCHMARKING; BIOMARKERS; CELL TRANSFORMATION, NEOPLASTIC; COLITIS; COLONIC POLYPS; COLONOSCOPY; CPG ISLANDS; DNA; DNA METHYLATION; FECES; HUMANS; PARASYMPATHOLYTICS; POLYPS; PRECANCEROUS CONDITIONS; RECTAL DISEASES; TERMINOLOGY AS TOPIC; WATCHFUL WAITING;

EID: 85020422477     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2017-314005     Document Type: Review

References (169)

1. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
2. Jaeschke R, Guyatt GH, Dellinger P, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ 2008;337:a744.
3. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975;36:2251-70.
4. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
5. East JE, Saunders BP, Jass JR. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history and clinical management. Gastroenterol Clin North Am 2008;37:25-46.
6. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010;138:2088-100.
7. Ijspeert JE, Vermeulen L, Meijer GA, et al. Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol 2015;12:401-9.
8. Lane N. The precursor tissue of ordinary large bowel cancer. Cancer Res 1976;36 (Pt 2):2669-72.
9. Bettington M, Walker N, Clouston A, et al. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013;62:367-86.
10. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38:787-93.
11. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol 2011;42:1-10.
12. Hughes LA, Khalid-de Bakker CA, Smits KM, et al. The CpG island methylator phenotype in colorectal cancer: progress and problems. Biochim Biophys Acta 2012;1825:77-85.
13. Chan TL, Zhao W, Leung SY, et al. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 2003;63:4878-81.
14. Park SJ, Rashid A, Lee JH, et al. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 2003;162:815-22.
15. Goldstein NS, Bhanot P, Odish E, et al. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 2003;119:778-96.
16. O'brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006;30:1491-501.
17. Sheridan TB, Fenton H, Lewin MR, et al. Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act". Am J Clin Pathol 2006;126:564-71.
18. Boparai KS, Dekker E, Polak MM, et al. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am J Pathol 2011;178:2700-7.
19. Tanaka M, Kusumi T, Sasaki Y, et al. Colonic intra-epithelial carcinoma occurring in a hyperplastic polyp via a serrated adenoma. Pathol Int 2001;51:215-20.
20. Yamauchi T, Watanabe M, Hasegawa H, et al. Serrated adenoma developing into advanced colon cancer in 2 years. J Gastroenterol 2002;37:467-70.
21. Oono Y, Fu K, Nakamura H, et al. Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci 2009;54:906-9.
22. Yamauchi M, Morikawa T, Kuchiba A, et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 2012;61:847-54.
23. Torlakovic EE, Gomez JD, Driman DK, et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 2008;32:21-9.
24. Kim KM, Lee EJ, Kim YH, et al. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol 2010;34:667-75.
25. Davis H, Irshad S, Bansal M, et al. Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche. Nat Med 2015;21:62-70.
26. Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315-29.
27. Whitehall VL, Walsh MD, Young J, et al. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 2001;61:827-30.
28. Sawhney MS, Farrar WD, Gudiseva S, et al. Microsatellite instability in interval colon cancers. Gastroenterology 2006;131:1700-5.
29. Arain MA, Sawhney M, Sheikh S, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 2010;105:1189-95.
30. Gill P, Rafferty H, Munday D, et al. Proximal colon cancer and serrated adenomas-hunting the missing 10%. Clin Med 2013;13:557-61.
31. Snover DC, Ahenen DJ, Burt RW, et al. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. World Health Organisation Classification of tumours of the digestive system. Lyon: IARC Press, 2010:160.
32. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology 1996;110:748-55.
33. Wong NA, Hunt LP, Novelli MR, et al. Observer agreement in the diagnosis of serrated polyps of the large bowel. Histopathology 2009;55:63-6.
34. Ensari A, Bilezikçi B, Carneiro F, et al. Serrated polyps of the colon: how reproducible is their classification? Virchows Arch 2012;461:495-504.
35. Payne SR, Church TR, Wandell M, et al. Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center. Clin Gastroenterol Hepatol 2014;12:1119-26.
36. Glatz K, Pritt B, Glatz D, et al. A multinational, internet-based assessment of observer variability in the diagnosis of serrated colorectal polyps. Am J Clin Pathol 2007;127:938-45.
37. Bateman AC, Shepherd NA. UK guidance for the pathological reporting of serrated lesions of the colorectum. J Clin Pathol 2015;68:585-91.
38. Kim SW, Cha JM, Lee JI, et al. A significant number of sessile serrated adenomas might not be accurately diagnosed in daily practice. Gut Liver 2010;4:498-502.
39. Khalid O, Radaideh S, Cummings OW, et al. Reinterpretation of histology of proximal colon polyps called hyperplastic in 2001. World J Gastroenterol 2009;15:3767-70.
40. Singh H, Bay D, Ip S, et al. Pathological reassessment of hyperplastic colon polyps in a city-wide pathology practice: implications for polyp surveillance recommendations. Gastrointest Endosc 2012;76:1003-8.
41. Hetzel JT, Huang CS, Coukos JA, et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol 2010;105:2656-64.
42. Jass JR, Young PJ, Robinson EM. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut 1992;33:1508-14.
43. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982;49:819-25.
44. Johannsen LG, Momsen O, Jacobsen NO. Polyps of the large intestine in Aarhus, Denmark. An autopsy study. Scand J Gastroenterol 1989;24:799-806.
45. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982;23:835-42.
46. Carr NJ, Mahajan H, Tan KL, et al. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 2009;62:516-18.
47. Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology 2005;47:32-40.
48. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 2010;63:681-6.
49. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006;131:1400-7.
50. Buda A, De Bone M, Dotti I, et al. Prevalence of different subtypes of serrated polyps and risk of synchronous advanced colorectal neoplasia in average-risk population undergoing first-time colonoscopy. Clin Transl Gastroenterol 2012;3:e6.
51. Álvarez C, Andreu M, Castells A, et al. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals. Gastrointest Endosc 2013;78:333-41.
52. Hazewinkel Y, de Wijkerslooth TR, Stoop EM, et al. Prevalence of serrated polyps and association with synchronous advanced neoplasia in screening colonoscopy. Endoscopy 2014;46:219-24.
53. Lee CK, Kim YW, Shim JJ, et al. Prevalence of proximal serrated polyps and conventional adenomas in an asymptomatic average-risk screening population. Gut Liver 2013;7:524-31.
54. Kahi CJ, Hewett DG, Norton DL, et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011;9:42-6.
55. Min YW, Lee JH, Lee SH, et al. Prevalence of proximal colon serrated polyps in a population at average risk undergoing screening colonoscopy: a multicenter study. Clin Res Hepatol Gastroenterol 2012;36:604-8.
56. Raju GS, Vadyala V, Slack R, et al. Adenoma detection in patients undergoing a comprehensive colonoscopy screening. Cancer Med 2013;2:391-402.
57. Freedman JS, Harari DY, Bamji ND, et al. The detection of premalignant colon polyps during colonoscopy is stable throughout the workday. Gastrointest Endosc 2011;73:1197-206.
58. Su MY, Hsu CM, Ho YP, et al. Comparative study of conventional colonoscopy, chromoendoscopy, and narrow-band imaging systems in differential diagnosis of neoplastic and nonneoplastic colonic polyps. Am J Gastroenterol 2006;101:2711-16.
59. Oka S, Tanaka S, Hiyama T, et al. Clinicopathologic and endoscopic features of colorectal serrated adenoma: differences between polypoid and superficial types. Gastrointest Endosc 2004;59:213-19.
60. Tadepalli US, Feihel D, Miller KM, et al. A morphologic analysis of sessile serrated polyps observed during routine colonoscopy (with video). Gastrointest Endosc 2011;74:1360-8.
61. Rustagi T, Rangasamy P, Myers M, et al. Sessile serrated adenomas in the proximal colon are likely to be flat, large and occur in smokers. World J Gastroenterol 2013;19:5271-7.
62. Hazewinkel Y, López-Cerón M, East JE, et al. Endoscopic features of sessile serrated adenomas: validation by international experts using high-resolution white-light endoscopy and narrow-band imaging. Gastrointest Endosc 2013;77:916-24.
63. Kimura T, Yamamoto E, Yamano HO, et al. A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma. Am J Gastroenterol 2012;107:460-9.
64. Ishigooka S, Nomoto M, Obinata N, et al. Evaluation of magnifying colonoscopy in the diagnosis of serrated polyps. World J Gastroenterol 2012;18:4308-16.
65. Kim MJ, Lee EJ, Suh JP, et al. Traditional serrated adenoma of the colorectum: clinicopathologic implications and endoscopic findings of the precursor lesions. Am J Clin Pathol 2013;140:898-911.
66. Rondagh EJ, Bouwens MW, Riedl RG, et al. Endoscopic appearance of proximal colorectal neoplasms and potential implications for colonoscopy in cancer prevention. Gastrointest Endosc 2012;75:1218-25.
67. Baxter NN, Sutradhar R, Forbes SS, et al. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology 2011;140:65-72.
68. East JE, Vieth M, Rex DK. Serrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance. Gut 2015;64:991-1000.
69. de Wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Differences in proximal serrated polyp detection among endoscopists are associated with variability in withdrawal time. Gastrointest Endosc 2013;77:617-23.
70. Butterly L, Robinson CM, Anderson JC, et al. Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. Am J Gastroenterol 2014;109:417-26.
71. Ket SN, Bird-Lieberman E, East JE. Electronic imaging to enhance lesion detection at colonoscopy. Gastrointest Endosc Clin N Am 2015;25:227-42.
72. Kahi CJ, Anderson JC, Waxman I, et al. High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening. Am J Gastroenterol 2010;105:1301-7.
73. Pohl J, Schneider A, Vogell H, et al. Pancolonic chromoendoscopy with indigo carmine versus standard colonoscopy for detection of neoplastic lesions: a randomised two-centre trial. Gut 2011;60:485-90.
74. Chandran S, Parker F, Vaughan R, et al. Right-sided adenoma detection with retroflexion versus forward-view colonoscopy. Gastrointest Endosc 2015;81:608-13.
75. Rondonotti E, Zolk O, Amato A, et al. The impact of hyoscine-N-butylbromide on adenoma detection during colonoscopy: meta-analysis of randomized, controlled studies. Gastrointest Endosc 2014;80:1103-12.
76. Anderson JC, Butterly LF, Robinson CM, et al. Impact of fair bowel preparation quality on adenoma and serrated polyp detection: data from the New Hampshire Colonoscopy Registry by using a standardized preparation-quality rating. Gastrointest Endosc 2014;80:463-70.
77. Leufkens AM, DeMarco DC, Rastogi A, et al. Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest Endosc 2011;73:480-9.
78. Gralnek IM, Siersema PD, Halpern Z, et al. Standard forward-viewing colonoscopy versus full-spectrum endoscopy: an international, multicentre, randomised, tandem colonoscopy trial. Lancet Oncol 2014;15:353-60.
79. Gralnek IM, Suissa A, Domanov S. Safety and efficacy of a novel balloon colonoscope: a prospective cohort study. Endoscopy 2014;46:883-7.
80. East JE, Stavrindis M, Thomas-Gibson S, et al. A comparative study of standard vs. high definition colonoscopy for adenoma and hyperplastic polyp detection with optimized withdrawal technique. Aliment Pharmacol Ther 2008;28:768-76.
81. Subramanian V, Mannath J, Hawkey CJ, et al. High definition colonoscopy vs. standard video endoscopy for the detection of colonic polyps: a meta-analysis. Endoscopy 2011;43:499-505.
82. Boparai KS, van den Broek FJ, van Eeden S, et al. Increased polyp detection using narrow band imaging compared with high resolution endoscopy in patients with hyperplastic polyposis syndrome. Endoscopy 2011;43:676-82.
83. Hazewinkel Y, Tytgat KM, van Leerdam ME, et al. Narrow-band imaging for the detection of polyps in patients with serrated polyposis syndrome: a multicenter, randomized, back-to-back trial. Gastrointest Endosc 2015;81:531-8.
84. Aminalai A, Rösch T, Aschenbeck J, et al. Live image processing does not increase adenoma detection rate during colonoscopy: a randomized comparison between FICE and conventional imaging (Berlin Colonoscopy Project 5, BECOP-5). Am J Gastroenterol 2010;105:2383-8.
85. Chung SJ, Kim D, Song JH, et al. Comparison of detection and miss rates of narrow band imaging, flexible spectral imaging chromoendoscopy and white light at screening colonoscopy: a randomised controlled back-to-back study. Gut 2014;63:785-91.
86. Pohl J, Lotterer E, Balzer C, et al. Computed virtual chromoendoscopy versus standard colonoscopy with targeted indigocarmine chromoscopy: a randomised multicentre trial. Gut 2009;58:73-8.
87. Hoffman A, Loth L, Rey JW, et al. High definition plus colonoscopy combined with i-scan tone enhancement vs. high definition colonoscopy for colorectal neoplasia: a randomized trial. Dig Liver Dis 2014;46:991-6.
88. Hong SN, Choe WH, Lee JH, et al. Prospective, randomized, back-to-back trial evaluating the usefulness of i-SCAN in screening colonoscopy. Gastrointest Endosc 2012;75:1011-21.
89. Testoni PA, Notaristefano C, Vailati C, et al. High-definition colonoscopy with i-Scan: better diagnosis for small polyps and flat adenomas. World J Gastroenterol 2012;18:5231-9.
90. Rex DK, Clodfelter R, Rahmani F, et al. Narrow-band imaging versus white light for the detection of proximal colon serrated lesions: a randomized, controlled trial. Gastrointest Endosc 2016;83:166-71.
91. Leung FW, Leung JW, Siao-Salera RM, et al. The water method significantly enhances detection of diminutive lesions (adenoma and hyperplastic polyp combined) in the proximal colon in screening colonoscopy-data derived from two RCT in US veterans. J Interv Gastroenterol 2011;1:48-52.
92. Corte C, Dahlenburg L, Selby W, et al. Hyoscine butylbromide administered at the cecum increases polyp detection: a randomized double-blind placebo-controlled trial. Endoscopy 2012;44:917-22.
93. Park SH, Kim SY, Lee SS, et al. Sensitivity of CT colonography for nonpolypoid colorectal lesions interpreted by human readers and with computer-aided detection. AJR Am J Roentgenol 2009;193:70-8.
94. Kim DH, Hinshaw JL, Lubner MG, et al. Contrast coating for the surface of flat polyps at CT colonography: a marker for detection. Eur Radiol 2014;24:940-6.
95. Waldock A, Ellis IO, Armitage NC, et al. Histopathological assessment of bleeding from polyps of the colon and rectum. J Clin Pathol 1989;42:378-82.
96. Heigh RI, Yab TC, Taylor WR, et al. Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT). PLoS ONE 2014;9:e85659.
97. Lidgard GP, Domanico MJ, Bruinsma JJ, et al. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clin Gastroenterol Hepatol 2013;11:1313-18.
98. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014;370:1287-97.
99. Rex DK, Adler SN, Aisenberg J, et al. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology 2015;148:948-57.
100. Hoff G, Bretthauer M, Garborg K, et al. New polyps, old tricks: controversy about removing benign bowel lesions. BMJ 2013;347:f5843.
101. Heldwein W, Dollhopf M, Rösch T, et al. The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies. Endoscopy 2005;37:1116-22.
102. Rutter MD, Nickerson C, Rees CJ, et al. Risk factors for adverse events related to polypectomy in the English Bowel Cancer Screening Programme. Endoscopy 2014;46:90-7.
103. Pohl H, Srivastava A, Bensen SP, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology 2013;144:74-80.
104. Rutter MD, Chattree A, Barbour JA, et al. British Society of Gastroenterology/Association of Coloproctologists of Great Britain and Ireland guidelines for the management of large non-pedunculated colorectal polyps. Gut 2015;64:1847-73.
105. Pellise M, Burgess NG, Tutticci N, et al. Endoscopic mucosal resection for large serrated lesions in comparison with adenomas: a prospective multicentre study of 2000 lesions. Gut 2017;66:644-53.
106. Binmoeller KF, Weilert F, Shah J, et al. "Underwater" EMR without submucosal injection for large sessile colorectal polyps (with video). Gastrointest Endosc 2012;75:1086-91.
107. Pattullo V, Bourke MJ, Tran KL, et al. The suction pseudopolyp technique: a novel method for the removal of small flat nonpolypoid lesions of the colon and rectum. Endoscopy 2009;41:1032-7.
108. Buchner AM, Guarner-Argente C, Ginsberg GG. Outcomes of EMR of defiant colorectal lesions directed to an endoscopy referral center. Gastrointest Endosc 2012;76:255-63.
109. Burgess NG, Metz AJ, Williams SJ, et al. Risk factors for intraprocedural and clinically significant delayed bleeding after wide-field endoscopic mucosal resection of large colonic lesions. Clin Gastroenterol Hepatol 2014;12:651-61.
110. Metz AJ, Bourke MJ, Moss A, et al. Factors that predict bleeding following endoscopic mucosal resection of large colonic lesions. Endoscopy 2011;43:506-11.
111. Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012;143:844-57.
112. Hassan C, Repici A, Rex DK. Serrated polyposis syndrome: risk stratification or reduction? Gut 2016;65:1070-2.
113. Oquiñena S, Guerra A, Pueyo A, et al. Serrated polyposis: prospective study of first-degree relatives. Eur J Gastroenterol Hepatol 2013;25:28-32.
114. Khashab M, Eid E, Rusche M, et al. Incidence and predictors of "late" recurrences after endoscopic piecemeal resection of large sessile adenomas. Gastrointest Endosc 2009;70:344-9.
115. Lu FI, van Niekerk de W, Owen D, et al. Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am J Surg Pathol 2010;34:927-34.
116. Pai RK, Hart J, Noffsinger AE. Sessile serrated adenomas strongly predispose to synchronous serrated polyps in non-syndromic patients. Histopathology 2010;56:581-8.
117. Lazarus R, Junttila OE, Karttunen TJ, et al. The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol 2005;123:349-59.
118. Teriaky A, Driman DK, Chande N. Outcomes of a 5-year follow-up of patients with sessile serrated adenomas. Scand J Gastroenterol 2012;47:178-83.
119. Salaria SN, Streppel MM, Lee LA, et al. Sessile serrated adenomas: high-risk lesions? Hum Pathol 2012;43:1808-14.
120. Schreiner MA, Weiss DG, Lieberman DA. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology 2010;139:1497-502.
121. Ng SC, Ching JY, Chan VC, et al. Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average-risk individuals. Aliment Pharmacol Ther 2015;41:108-15.
122. Hiraoka S, Kato J, Fujiki S, et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology 2010;139:1503-10, 1510.
123. Holme Ø, Bretthauer M, Eide TJ, et al. Long-term risk of colorectal cancer in individuals with serrated polyps. Gut 2015;64:929-36.
124. Li D, Jin C, McCulloch C, et al. Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol 2009;104:695-702.
125. Rondagh EJ, Masclee AA, Bouwens MW, et al. Endoscopic red flags for the detection of high-risk serrated polyps: an observational study. Endoscopy 2011;43:1052-8.
126. Burgess NG, Pellise M, Nanda KS, et al. Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps. Gut 2016;65:437-46.
127. Kim HY, Kim SM, Seo JH, et al. Age-specific prevalence of serrated lesions and their subtypes by screening colonoscopy: a retrospective study. BMC Gastroenterol 2014;14:82.
128. Erichsen R, Baron JA, Hamilton-Dutoit SJ, et al. Increased risk of colorectal cancer development among patients with serrated polyps. Gastroenterology 2016;150:895-902.
129. Hassan C, Quintero E, Dumonceau JM, et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2013;45:842-51.
130. Xu S, Wang L, Yang G, et al. Clinicopathological observations of colorectal serrated lesions associated with invasive carcinoma and high-grade intraepithelial neoplasm. Exp Ther Med 2013;6:1113-20.
131. Ban S, Mitomi H, Horiguchi H, et al. Adenocarcinoma arising in small sessile serrated adenoma/polyp (SSA/P) of the colon: clinicopathological study of eight lesions. Pathol Int 2014;64:123-32.
132. Goldstein NS. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am J Clin Pathol 2006;125:132-45.
133. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013;369:1095-105.
134. Biswas S, Ellis AJ, Guy R, et al. High prevalence of hyperplastic polyposis syndrome (serrated polyposis) in the NHS Bowel Cancer Screening Programme. Gut 2013;62:475.
135. Kahi CJ, Li X, Eckert GJ, et al. High colonoscopic prevalence of proximal colon serrated polyps in average-risk men and women. Gastrointest Endosc 2012;75:515-20.
136. Lockett M, Atkin WS. Hyperplastic polyposis: prevalence and cancer risk. Gut 2001;49(Suppl 1):A4 [abstract].
137. Moreira L, Pellisé M, Carballal S, et al. High prevalence of serrated polyposis syndrome in FIT-based colorectal cancer screening programmes. Gut 2013;62:476-7.
138. Orlowska J, Kiedrowski M, Kaminski MF. Hyperplastic polyposis syndrome in asymptomatic patients: the result from the colorectal-cancer screening program. Virchows Arch 2009;455(Suppl 1):S47.
139. Williams GT, Arthur JF, Bussey HJ, et al. Metaplastic polyps and polyposis of the colorectum. Histopathology 1980;4:155-70.
140. Boparai KS, Mathus-Vliegen EM, Koornstra JJ, et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010;59:1094-100.
141. Edelstein DL, Axilbund JE, Hylind LM, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut 2013;62:404-8.
142. Ijspeert JE, Rana SA, Atkinson NS, et al. Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis. Gut 2017;66:278-84.
143. Carballal S, Rodríguez-Alcalde D, Moreira L, et al. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study. Gut 2016;65:1829-37.
144. Boparai KS, Reitsma JB, Lemmens V, et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut 2010;59:1222-5.
145. Win AK, Walters RJ, Buchanan DD, et al. Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol 2012;107:770-8.
146. Hazewinkel Y, Reitsma JB, Nagengast FM, et al. Extracolonic cancer risk in patients with serrated polyposis syndrome and their first-degree relatives. Fam Cancer 2013;12:669-73.
147. Cheah PY, Wong YH, Chau YP, et al. Germline bone morphogenesis protein receptor 1A mutation causes colorectal tumorigenesis in hereditary mixed polyposis syndrome. Am J Gastroenterol 2009;104:3027-33.
148. Mongin C, Coulet F, Lefevre JH, et al. Unexplained polyposis: a challenge for geneticists, pathologists and gastroenterologists. Clin Genet 2012;81:38-46.
149. Heald B, Mester J, Rybicki L, et al. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology 2010;139:1927-33.
150. Sweet K, Willis J, Zhou XP, et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 2005;294: 2465-73.
151. Jaeger E, Leedham S, Lewis A, et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet 2012;44:699-703.
152. Gala MK, Mizukami Y, Le LP, et al. Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas. Gastroenterology 2014;146:520-9.
153. Clendenning M, Young JP, Walsh MD, et al. Germline mutations in the polyposis-associated genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 are not common in individuals with serrated polyposis syndrome. PLoS ONE 2013; 8:e66705.
154. Hazewinkel Y, Tytgat KM, van Eeden S, et al. Incidence of colonic neoplasia in patients with serrated polyposis syndrome who undergo annual endoscopic surveillance. Gastroenterology 2014;147:88-95.
155. Leonard DF, Dozois EJ, Smyrk TC, et al. Endoscopic and surgical management of serrated colonic polyps. Br J Surg 2011;98:1685-94.
156. Bossard C, Denis MG, Bézieau S, et al. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis. Oncol Rep 2007;18:1093-7.
157. Rubio CA. Serrated neoplasias and de novo carcinomas in ulcerative colitis: a histological study in colectomy specimens. J Gastroenterol Hepatol 2007;22:1024-31.
158. Rubio CA, Befrits R, Jaramillo E, et al. Villous and serrated adenomatous growth bordering carcinomas in inflammatory bowel disease. Anticancer Res 2000;20:4761-4.
159. Aust DE, Haase M, Dobryden L, et al. Mutations of the BRAF gene in ulcerative colitis-related colorectal carcinoma. Int J Cancer 2005;115:673-7.
160. Odze RD, Brien T, Brown CA, et al. Molecular alterations in chronic ulcerative colitis-associated and sporadic hyperplastic polyps: a comparative analysis. Am J Gastroenterol 2002;97:1235-42.
161. Srivastava A, Redston M, Farraye FA, et al. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Am J Surg Pathol 2008;32:296-303.
162. Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Am J Gastroenterol 2006;101:873-85.
163. Anderson JC, Butterly LF, Goodrich M, et al. Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the New Hampshire colonoscopy registry. Clin Gastroenterol Hepatol 2013;11:1308-12.
164. Leung WK, Tang V, Lui PC. Detection rates of proximal or large serrated polyps in Chinese patients undergoing screening colonoscopy. J Dig Dis 2012;13: 466-71.
165. Liang J, Kalady MF, Appau K, et al. Serrated polyp detection rate during screening colonoscopy. Colorectal Dis 2012;14:1323-7.
166. Gurudu SR, Heigh RI, De Petris G, et al. Sessile serrated adenomas: demographic, endoscopic and pathological characteristics. World J Gastroenterol 2010;16:3402-5.
167. Kumbhari V, Behary J, Hui JM. Prevalence of adenomas and sessile serrated adenomas in Chinese compared with Caucasians. J Gastroenterol Hepatol 2013;28:608-12.
168. Rex DK, Bond JH, Winawer S, et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002;97:1296-308.
169. Ijspeert JE, van Doorn SC, van der Brug YM, et al. The proximal serrated polyp detection rate is an easy-to-measure proxy for the detection rate of clinically relevant serrated polyps. Gastrointest Endosc 2015;82:870-7.